FXN and Friedreich ataxia: A subset of specific CpG sites in the FXN promoter and exon 1 are completely methylation-free in unaffected individuals but predominantly methylated in FRDA patients’ blood, brain, cerebellum and heart tissues (Greene et al., 2007; Al-Mahdawi et al., 2008).